Efficacy Assessment of Intradermal Stromal Vascular Fraction Injection Compared to Saline Injection for Treating Atrophic Acne Scars: A 10-Week, Prospective, Randomized, Split-Face, Single-Blind Study - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Efficacy Assessment of Intradermal Stromal Vascular Fraction Injection Compared to Saline Injection for Treating Atrophic Acne Scars: A 10-Week, Prospective, Randomized, Split-Face, Single-Blind Study

  • By

  • Joong Heon Suh

  • Ji-Young Kim

  • Ji Young Yoon

  • Jun Hyo Lee

  • Dong Hyo Kim

  • Ungsik Jin

  • Dae Hun Suh

  • December 18, 2025

Share

Clinical Scorecard: Efficacy Assessment of Intradermal Stromal Vascular Fraction Injection Compared to Saline Injection for Treating Atrophic Acne Scars: A 10-Week, Prospective, Randomized, Split-Face, Single-Blind Study

At a Glance

CategoryDetail
Condition
Key MechanismsSVF enhances epidermal progenitor activity and dermal matrix remodeling, as evidenced by study results.
Target Population
Care Setting

Key Highlights

  • Intradermal SVF injection significantly reduced scar counts (p-value needed).
  • ECCA and SGA scores improved with SVF compared to saline (specific values needed).
  • SVF shows potential as a regenerative monotherapy for atrophic acne scars.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • A
      • s
      • s
      • e
      • s
      • s
      • s
      • c
      • a
      • r
      • c
      • o
      • u
      • n
      • t
      • s
      • a
      • n
      • d
      • E
      • C
      • C
      • A
      • /
      • S
      • G
      • A
      • s
      • c
      • o
      • r
      • e
      • s
      • p
      • o
      • s
      • t
      • -
      • t
      • r
      • e
      • a
      • t
      • m
      • e
      • n
      • t
      • a
      • t
      • 4
      • ,
      • 8
      • ,
      • a
      • n
      • d
      • 1
      • 0
      • w
      • e
      • e
      • k
      • s
      • .

      Risks

        Patient & Prescribing Data

        SVF derived from autologous adipose tissue shows regenerative properties; monitor for potential side effects.

        Clinical Best Practices

        • Use SVF as a monotherapy for atrophic acne scars.
        • Ensure informed consent and ethical approval before treatment.
        • Select patients without keloidal tendencies or serious comorbidities.

        Related Resources & Content

        Original Source(s)

        Related Content